Pancreatic Cancer Trial, Recruiting (NCT05195281)

Pancreatic Cancer Trial, Recruiting NCT05195281 Sponsor: IRCCS San Raffaele Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05195281 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who are willing to sign a consent form agreeing to take part in the trial
People who have had a CT scan, MRI, or endoscopic ultrasound (a camera procedure to look inside the body) showing that a pancreatic lesion is locally advanced (meaning the tumour has grown but has not spread far from the pancreas)
People who have already had a tissue sample taken from a solid pancreatic lesion using endoscopic ultrasound, and that sample confirmed a type of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC)
People who are currently receiving chemotherapy before possible surgery (known as neoadjuvant chemotherapy)
People whose main care is being provided at San Raffaele Hospital

Who may not be able to join:

People who are not willing to sign the consent form
People who are pregnant or currently breastfeeding
People whose tissue sample showed a cancer type other than PDAC
People whose cancer has been found to have progressed (gotten worse) on a follow-up CT scan done to check how treatment is working

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39-02-26432471

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05195281

Sponsor: IRCCS San Raffaele

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: +39-02-26432471

More information: https://clinicaltrials.gov/study/NCT05195281

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who are willing to sign a consent form agreeing to take part in the trial
People who have had a CT scan, MRI, or endoscopic ultrasound (a camera procedure to look inside the body) showing that a pancreatic lesion is locally advanced (meaning the tumour has grown but has not spread far from the pancreas)
People who have already had a tissue sample taken from a solid pancreatic lesion using endoscopic ultrasound, and that sample confirmed a type of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC)
People who are currently receiving chemotherapy before possible surgery (known as neoadjuvant chemotherapy)
People whose main care is being provided at San Raffaele Hospital

Who may not be able to join:

People who are not willing to sign the consent form
People who are pregnant or currently breastfeeding
People whose tissue sample showed a cancer type other than PDAC
People whose cancer has been found to have progressed (gotten worse) on a follow-up CT scan done to check how treatment is working

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS San Raffaele

Registry

ClinicalTrials.gov

Start date

14 July 2021

Est. completion

28 September 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Evaluation of molecular subtype modification

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov